Stimulation of the hypothalamic-pituitary-adrenal axis and inhibition of growth hormone release via increased central noradrenaline neuronal activity by urethane anaesthesia in the rat: blockade by clonidine.
Computerized gas chromatography-mass spectrometry was used to measure precisely the hypothalamic levels of noradrenaline (NA), dopamine and serotonin together with those of their major neuronal metabolites 3,4-dihydroxyphenylethyleneglycol (DHPG), 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in normal male rats 45 min after stimulation of hypothalamic-pituitary-adrenal function by urethane (1.3 g/kg) administration. Urethane treatment resulted in a significant elevation of central noradrenergic neuronal activity (NNA) as assessed from marked rises in hypothalamic DHPG concentrations and the ratio (DHPG/NA). At the same time there was significant stimulation of ACTH and corticosterone release and inhibition of growth hormone release. These hormonal and central effects of urethane (but not anesthesia) were inhibited when the alpha 2-agonist clonidine (150 micrograms/kg) was co-administered. Urethane had no major effect on hypothalamic dopamine or serotonin status. We propose that the release of ACTH and the suppression of growth hormone release following urethane anaesthesia is a result of activation of central NNA and suggest that the hormonal responses are mediated via hypothalamic noradrenergic facilitation of corticotrophin releasing factor and somatostatin release to the anterior pituitary.
Smythe
G A
GA
Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, N.S.W.
Gleeson
R M
RM
Stead
B H
BH
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000758:Anesthesia; D000818:Animals; D003000:Clonidine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004702:Endocrine Glands / Q000187:drug effects* / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism* / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014520:Urethane / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D012701:Serotonin; D014520:Urethane; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D003000:Clonidine; D004298:Dopamine; D009638:Norepinephrine